Anti-angiogenic molecule, soluble Fms-like tyrosine kinase-1 (SFLT-1), is produced by alternative splicing of the FLT-1 gene that can be bound to VEGF and leads to endothelial dysfunction and prevent angiogenesis in placenta. This evidence concerns the gene FLT1 and endothelial dysfunction.